4//SEC Filing
Goldan Keith A. 4
Accession 0000950170-25-019005
CIK 0001395937other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:16 PM ET
Size
4.7 KB
Accession
0000950170-25-019005
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-02-10$15.50/sh−3,777$58,559→ 90,746 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001495411
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:16 PM ET
- Size
- 4.7 KB